Home grown FMCG firm Emami has enetered into a partnership with German homoeopathic firm Hevert-Arzneimittel for manufacturing and marketing of select Hevert formulations in India.
Emami through its homoeopathy arms M Bhattacharyya & Co and King & Co (Homoeo Chemist) has forged alliance with the German firm Hevert-Arzneimittel for "distribution & marketing, GMP Consultancy and licence for manufacturing select Hevert formulations in India", the firm said in a statement.
As per the agreement, Hevert-Arzneimittel products will be available in 400 homoeopathy medicine retail outlets across diverse distribution channels.
Commenting on it Emami Group Founder & Joint Chairman R S Agarwal said: "We were always open for strategic technical collaboration with international homoeopathic firms and I am confident that our partnership with Hevert is going to benefit the consumers in India immensely."
Established in 1889, M. Bhattacharyya and King & Co was acquired by Emami Group in 2011. It is one of the leading player of Rs 1,500 crore homoeopathy pharma market which is growing 25 per cent annually.
